Cellular and humoral response to the fourth BNT162b2 mRNA COVID-19 vaccine dose in patients with CLL. Benjamini O, Gershon R, Bar-Haim E, Lustig Y, et al. Eur J Haematol 2023;110:99-108.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Benjamini O, Gershon R, Bar-Haim E, Lustig Y, et al. Cellular and humoral response to the fourth BNT162b2 mRNA COVID-19 vaccine dose in patients with CLL. Eur J Haematol 2023;110:99-108.
PMID: 36208015